Skip to main content

Advertisement

SpringerLink
Log in

Cytokine response in inflammatory myopathies

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

After background information about pathologic findings, this review focuses on the cytokine response in the pathogenesis of polymyositis and dermatomyositis. Cytokines are important mediators of the immune response and play a key role in these diseases by acting on inflammatory immune cells, muscle cells, and vessel cells. Various cytokines are found in myositis samples, in particular interleukin-1 and tumor necrosis factor-α, which are associated with the migration, differentiation, and maturation of inflammatory cells. Recent advances indicate that the muscle cell itself could participate in the inflammatory process. Cytokines promote changes in muscle metabolism resulting in a self-sustaining inflammatory response. Accordingly, cytokines may represent new targets for therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Emslie-Smith AM, Arahata K, Engel AG: Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989, 20:224–231.

    Article  PubMed  CAS  Google Scholar 

  2. Bartocionni E, Gallucci S, Scuderi F, et al.: MHC class I, MHC class II and intercellular adhesion molecule-1 expression in inflammatory myopathies. Clin Exp Immunol 1994, 95:166–172.

    Article  Google Scholar 

  3. Hoogendijk JE, Amato AA, Lecky BR, et al.: 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis. Neuromuscular Disorders 2004, 14:337–345.

    Article  PubMed  Google Scholar 

  4. Page G, Chevrel G, Miossec P: Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum 2004, 50:199–208.

    Article  PubMed  CAS  Google Scholar 

  5. Dalakas MC, Hohlfeld R: Polymyositis and dermatomyositis. Lancet 2003, 362:971–982.

    Article  PubMed  CAS  Google Scholar 

  6. Lundberg I, Ulfgren AK, Nyberg P, et al.: Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997, 40:865–874.

    Article  PubMed  CAS  Google Scholar 

  7. Lepidi H, Frances V, Figarella-Branger D, et al.: Local expression of cytokines in idiopathic inflammatory myopathies. Neuropathol Appl Neurobiol 1998, 24:73–79.

    Article  PubMed  CAS  Google Scholar 

  8. Tews DS, Goebel HH: Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol 1996, 55:342–347.

    PubMed  CAS  Google Scholar 

  9. De Bleecker JL, Meire VI, Declercq W, Van Aken EH: Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. Neuromuscul Disord 1999, 9:239–246.

    Article  PubMed  Google Scholar 

  10. Grundtman C, Salomonsson S, Dorph C, et al.: Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. Arthritis Rheum 2007, 56:674–687.

    Article  PubMed  Google Scholar 

  11. Lundberg I, Brengman JM, Engel AG: Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. J Neuroimmunol 1995, 63:9–16.

    Article  PubMed  CAS  Google Scholar 

  12. Adams EM, Kirkley J, Eidelman G, et al.: The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases. Proc Assoc Am Physicians 1997, 109:275–285.

    PubMed  CAS  Google Scholar 

  13. Harrington LE, Hatton RD, Mangan PR, et al.: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123–1132.

    Article  PubMed  CAS  Google Scholar 

  14. Park H, Li Z, Yang XO, et al.: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133–1141.

    Article  PubMed  CAS  Google Scholar 

  15. Miossec P: Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum 2003, 48:594–601.

    Article  PubMed  CAS  Google Scholar 

  16. Chabaud M, Fossiez F, Taupin JL, Miossec P: Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 1998, 161:409–414.

    PubMed  CAS  Google Scholar 

  17. Chevrel G, Page G, Granet C, et al.: Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol 2003, 137:125–133.

    Article  PubMed  CAS  Google Scholar 

  18. Amemiya K, Semino-Mora C, Granger RP, Dalakas MC: Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin. Clin Immunol 2000, 94:99–104.

    Article  PubMed  CAS  Google Scholar 

  19. Gallucci S, Provenzano C, Mazzarelli P, et al.: Myoblasts produce IL-6 in response to inflammatory stimuli. Int Immunol 1998, 10:267–273.

    Article  PubMed  CAS  Google Scholar 

  20. Nagaraju K, Raben N, Merritt G, et al.: A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 1998, 113:407–414.

    Article  PubMed  CAS  Google Scholar 

  21. Chevrel G, Granet C, Miossec P: Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis 2005, 64:1257–1262.

    Article  PubMed  CAS  Google Scholar 

  22. Jo C, Kim H, Jo I, et al.: Leukemia inhibitory factor blocks early differentiation of skeletal muscle cells by activating ERK. Biochim Biophys Acta 2005, 1743:187–197.

    Article  PubMed  CAS  Google Scholar 

  23. Ebisui C, Tsujinaka T, Morimoto T, et al.: Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin Sci (Lond) 1995, 89:431–439.

    CAS  Google Scholar 

  24. Austin L, Burgess AW: Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines. J Neurol Sci 1991, 101:193–197.

    Article  PubMed  CAS  Google Scholar 

  25. Langen RC, van der Velden JL, Schols AM, et al.: Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J 2004, 18:227–237.

    Article  PubMed  CAS  Google Scholar 

  26. De Rossi M, Bernasconi P, Baggi F, et al.: Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 2000, 12:1329–1335.

    Article  PubMed  Google Scholar 

  27. Nagaraju K, Raben N, Loeffler L, et al.: Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A 2000, 97:9209–9214.

    Article  PubMed  CAS  Google Scholar 

  28. Lundberg I, Ulfgren AK, Nyberg P, et al.: Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997, 40:865–874.

    Article  PubMed  CAS  Google Scholar 

  29. Nyberg P, Wikman AL, Nennesmo I, Lundberg I: Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 2000, 27:940–948.

    PubMed  CAS  Google Scholar 

  30. Shreeniwas R, Koga S, Karakurum M: Hypoxia-mediated induction of endothelial cell interleukine-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Investigation 1992, 90:2333–2339.

    CAS  Google Scholar 

  31. De Bleecker JL, Engel AG: Expression of cell adhesion molecules in inflammatory myopathies and Dechenne dystrophy. J Neuropathol Exp Neurol 1994, 53:369–376.

    Article  PubMed  Google Scholar 

  32. Nagaraju K, Rider LG, Fan C, et al.: Endothelial cell activation and neovascularization are prominent in dermatomyositis. J Autoimmune Dis 2006, 3:2.

    Article  PubMed  CAS  Google Scholar 

  33. Civatte M, Bartoli C, Schleinitz N, et al.: Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies. Neuropathol Appl Neurobiol 2005, 31:70–79.

    Article  PubMed  CAS  Google Scholar 

  34. Casciola-Rosen L, Nagaraju K, Plotz P, et al.: Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005, 201:591–601.

    Article  PubMed  CAS  Google Scholar 

  35. Howard OM, Dong HF, Yang D, et al.: Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 2002, 196:781–791.

    Article  PubMed  CAS  Google Scholar 

  36. Levine SM, Rosen A, Casciola-Rosen LA: Anti-aminoacyl tRNA synthetase immune responses: insights into the pathogenesis of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 2003, 15:708–713.

    Article  PubMed  CAS  Google Scholar 

  37. Nagaraju K, Casciola-Rosen L, Lundberg I, et al.: Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005, 52:1824–1835.

    Article  PubMed  CAS  Google Scholar 

  38. Wiendl H, Hohlfeld R, Kieseier BC: Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol 2005, 26:373–380.

    Article  PubMed  CAS  Google Scholar 

  39. Iannone F, Scioscia C, Falappone PC, et al.: Use of etanercept in the treatment of dermatomyositis: a case series. J Rheumatol 2006, 33:1802–1804.

    PubMed  CAS  Google Scholar 

  40. Efthimiou P, Schwartzman S, Kagen LJ: Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients. Ann Rheum Dis 2006, 65:1233–1236.

    Article  PubMed  CAS  Google Scholar 

  41. Chabaud M, Page G, Miossec P: Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol 2001, 167:6015–6020.

    PubMed  CAS  Google Scholar 

  42. Noss EH, Hausner-Sypek DL, Weinblatt ME: Rituximab as therapy for refractory polymyositis and dermatomyositis. J Rheumatol 2006, 33:1021–1026.

    PubMed  Google Scholar 

  43. Levine TD: Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 2005, 52:601–607.

    Article  PubMed  CAS  Google Scholar 

  44. Kremer JM, Dougados M, Emery P, et al.: Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005, 52:2263–2271.

    Article  PubMed  CAS  Google Scholar 

  45. Nagaraju K, Raben N, Villalba ML, et al.: Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells. Clin Immunol 1999, 92:161–169.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Immunology Unit, Department of Immunology and Rheumatology, Hospital Edouard Herriot, 69437, Lyon Cedex 03, France

    Pierre Miossec MD, PhD

Authors
  1. Anne Tournadre MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre Miossec MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pierre Miossec MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tournadre, A., Miossec, P. Cytokine response in inflammatory myopathies. Curr Rheumatol Rep 9, 286–290 (2007). https://doi.org/10.1007/s11926-007-0046-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-007-0046-6

Search

Navigation